An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients. [PDF]
Goi N+4 more
europepmc +1 more source
Quality of life and mental health status in caregivers of pediatric patients with nephropathic cystinosis. [PDF]
González K+3 more
europepmc +1 more source
3D Bioprintable Self-Healing Hyaluronic Acid Hydrogel with Cysteamine Grafting for Tissue Engineering. [PDF]
Nagaraja K+5 more
europepmc +1 more source
Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles. [PDF]
Ha E, Kang H, Noh H.
europepmc +1 more source
Harnessing Novel Reduced Graphene Oxide-Based Aerogel for Efficient Organic Contaminant and Heavy Metal Removal in Aqueous Environments. [PDF]
Madduri SB, Kommalapati RR.
europepmc +1 more source
Ocular Involvement in Infantile Cystinosis: A Case Report. [PDF]
Razzak A+3 more
europepmc +1 more source
Intermediate cystinosis: a case report of 10-year treatment with cysteamine. [PDF]
Kawamura M+9 more
europepmc +1 more source
Cystine crystal nucleation and decay in the context of cystinuria pathogenesis and treatment. [PDF]
Noble K, Kavanagh ON.
europepmc +1 more source
Supplementation of lake extender with cysteamine preserves quality parameters and fertility potential of post-thawed rooster sperm during cryopreservation process. [PDF]
Masoudi R+7 more
europepmc +1 more source